1. Home
  2. GCT vs EVO Comparison

GCT vs EVO Comparison

Compare GCT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GigaCloud Technology Inc

GCT

GigaCloud Technology Inc

HOLD

Current Price

$38.01

Market Cap

1.2B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
EVO
Founded
2019
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GCT
EVO
Price
$38.01
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$33.00
$7.00
AVG Volume (30 Days)
615.7K
39.3K
Earning Date
05-08-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
N/A
EPS
1.04
N/A
Revenue
$1,161,042,000.00
N/A
Revenue This Year
$14.43
$1.37
Revenue Next Year
$6.78
$10.05
P/E Ratio
$36.50
N/A
Revenue Growth
64.96
N/A
52 Week Low
$20.71
$1.95
52 Week High
$51.82
$4.42

Technical Indicators

Market Signals
Indicator
GCT
EVO
Relative Strength Index (RSI) 63.52 24.34
Support Level $37.46 N/A
Resistance Level $43.64 $3.36
Average True Range (ATR) 1.49 0.10
MACD 0.72 -0.09
Stochastic Oscillator 84.18 4.08

Price Performance

Historical Comparison
GCT
EVO

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: